KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exelixis (EXEL) Liabilities and Shareholders Equity (2016 - 2026)

Exelixis (EXEL) has 16 years of Liabilities and Shareholders Equity data on record, last reported at $2.8 billion in Q1 2026.

  • For Q1 2026, Liabilities and Shareholders Equity fell 3.5% year-over-year to $2.8 billion; the TTM value through Jan 2026 reached $11.2 billion, down 2.63%, while the annual FY2026 figure was $2.8 billion, 3.5% down from the prior year.
  • Liabilities and Shareholders Equity reached $2.8 billion in Q1 2026 per EXEL's latest filing, up from $2.8 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $3.1 billion in Q1 2023 and bottomed at $2.7 billion in Q2 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $2.9 billion, with a median of $2.9 billion recorded in 2023.
  • Peak YoY movement for Liabilities and Shareholders Equity: rose 20.98% in 2022, then decreased 11.75% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $3.1 billion in 2022, then decreased by 4.2% to $2.9 billion in 2023, then increased by 0.61% to $3.0 billion in 2024, then fell by 4.62% to $2.8 billion in 2025, then rose by 0.74% to $2.8 billion in 2026.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $2.8 billion in Q1 2026, $2.8 billion in Q4 2025, and $2.7 billion in Q3 2025.